The Trump administration jumped into a fight with drugmakers Wednesday by promising to allow importation of cheaper drugs from Canada and other countries, advancing an idea the pharmaceutical industry and many members of the president's party have long opposed.
Trump's health department Wednesday said it would open up two pathways to let states and companies test drug importing programs in the coming months, promising that modern drug distribution supply chains would allow federal drug regulators to guarantee the products' safety.
